Tag Archives: Steven Halper

Cantor Fitzgerald Thinks Tabula Rasa HealthCare’s Stock is Going to Recover

In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Tabula Rasa HealthCare (TRHC – Research Report), with a price target of $99. The company’s shares closed on Friday at $46.79, close to its 52-week

Computer Programs and Systems, Inc. (CPSI) Receives a Hold from Cantor Fitzgerald

Cantor Fitzgerald analyst Steven Halper reiterated a Hold rating on Computer Programs and Systems, Inc. (CPSI – Research Report) yesterday and set a price target of $32. The company’s shares closed yesterday at $30.05. Halper wrote: “. We reiterate our

Allscripts (MDRX) Gets a Hold Rating from Cantor Fitzgerald

In a report released yesterday, Steven Halper from Cantor Fitzgerald reiterated a Hold rating on Allscripts (MDRX – Research Report), with a price target of $10. The company’s shares closed yesterday at $9.94. Halper commented: “. We reiterate our Neutral

Cantor Fitzgerald Reiterates a Buy Rating on Benefitfocus (BNFT)

In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Benefitfocus (BNFT – Research Report), with a price target of $60. The company’s shares opened today at $39.78. Halper commented: “. We reiterate our Overweight

CVS Health (CVS) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Steven Halper reiterated a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $80. The company’s shares opened today at $56.85. Halper said: “. We reiterate our Overweight on CVS

Cantor Fitzgerald Keeps a Hold Rating on Teladoc (TDOC)

Cantor Fitzgerald analyst Steven Halper reiterated a Hold rating on Teladoc (TDOC – Research Report) today and set a price target of $70. The company’s shares opened today at $56.88. Halper commented: “. We reiterate our Neutral rating on TDOC